Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1838]

Phase III trial data supports current standard 12-month adjuvant trastuzumab...

Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland

Phase III trial data supports current standard 12-month adjuvant trastuzumab for HER2-positive breast cancer ( Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland )

Temporary ovarian suppression with hormone analogue may preserve fertility...

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )

Two years of extended anastrozole therapy as effective as five

Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria

Two years of extended anastrozole therapy as effective as five ( Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )

Tandem duplicator phenotypes define 50% of triple negative breast cancers

Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA

Tandem duplicator phenotypes define 50% of triple negative breast cancers ( Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA )

Updated genomic screening tool for life-time breast cancer risk

Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...

Updated genomic screening tool for life-time breast cancer risk ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )

Temporary ovarian suppression with hormone analogue may preserve fertility...

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )

Acupuncture significantly reduces joint pain for breast cancer patients

Prof Dawn Hershman - Columbia University Medical Center, New York, NY

Acupuncture significantly reduces joint pain for breast cancer patients ( Prof Dawn Hershman - Columbia University Medical Center, New York, NY )

Immunotherapy shows early promise for patients with trastuzumab-resistant...

Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

Immunotherapy shows early promise for patients with trastuzumab-resistant breast cancer ( Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

HR–positive advanced breast cancer: Ribociclib improved PFS for pre and...

Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA

HR–positive advanced breast cancer: Ribociclib improved PFS for pre and perimenopausal women ( Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA )

HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive...

Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California...

HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive disease free survival ( Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California, USA )

Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast...

Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California...

Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast cancer ( Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California, USA )

Increasing the dose intensity of chemotherapy may lower the risk of breast...

Prof Richard Gray - University of Oxford, Oxford, UK

Increasing the dose intensity of chemotherapy may lower the risk of breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, UK )

More from ecancer